CORCEPT THERAPEUTICS INC Share-based Payment Arrangement, Amount Capitalized
CORCEPT THERAPEUTICS INC (CORT) reported Share-based Payment Arrangement, Amount Capitalized of $481.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $481.00K, a 349.53% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $162.00K, a 12.50% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $94.00K, a 8.74% decline year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $141.00K, a 48.42% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for fiscal 2025 was $486.00K, a 49.08% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for fiscal 2024 was $326.00K, a 56.73% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for fiscal 2023 was $208.00K, a 25.71% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, amount capitalized for fiscal 2022 was $280.00K, a 18.14% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $481.00K 10-Q · filed 2026-07-29 | $643.00K 10-Q · filed 2026-07-29 | $737.00K derived: sum of 3 quarters · filed 2026-07-29 | $878.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $162.00K 10-Q · filed 2026-04-30 | $256.00K derived: sum of 2 quarters · filed 2026-04-30 | $397.00K derived: sum of 3 quarters · filed 2026-04-30 | $504.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $235.00K derived: sum of 2 quarters · filed 2026-02-24 | $342.00K derived: sum of 3 quarters · filed 2026-07-29 | $486.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $141.00K 10-Q · filed 2025-11-04 | $248.00K derived: sum of 2 quarters · filed 2026-07-29 | $392.00K 10-Q · filed 2025-11-04 | $495.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $107.00K 10-Q · filed 2026-07-29 | $251.00K 10-Q · filed 2026-07-29 | $354.00K derived: sum of 3 quarters · filed 2026-07-29 | $449.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $144.00K 10-Q · filed 2026-04-30 | $247.00K derived: sum of 2 quarters · filed 2026-04-30 | $342.00K derived: sum of 3 quarters · filed 2026-04-30 | $425.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $198.00K derived: sum of 2 quarters · filed 2026-02-24 | $281.00K derived: sum of 3 quarters · filed 2026-02-24 | $326.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $95.00K 10-Q · filed 2025-11-04 | $178.00K derived: sum of 2 quarters · filed 2025-11-04 | $223.00K 10-Q · filed 2025-11-04 | $261.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $83.00K 10-Q · filed 2025-07-31 | $128.00K 10-Q · filed 2025-07-31 | $166.00K derived: sum of 3 quarters · filed 2026-02-24 | $210.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $45.00K 10-Q · filed 2025-05-05 | $83.00K derived: sum of 2 quarters · filed 2026-02-24 | $127.00K derived: sum of 3 quarters · filed 2026-02-24 | $161.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $82.00K derived: sum of 2 quarters · filed 2026-02-24 | $116.00K derived: sum of 3 quarters · filed 2026-02-24 | $208.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | $44.00K 10-Q · filed 2024-10-30 | $78.00K derived: sum of 2 quarters · filed 2024-10-30 | $170.00K 10-Q · filed 2024-10-30 | $253.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $34.00K 10-Q · filed 2024-07-29 | $126.00K 10-Q · filed 2024-07-29 | $209.00K derived: sum of 3 quarters · filed 2025-02-26 | $286.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $92.00K 10-Q · filed 2024-05-01 | $175.00K derived: sum of 2 quarters · filed 2025-02-26 | $252.00K derived: sum of 3 quarters · filed 2025-02-26 | $308.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $160.00K derived: sum of 2 quarters · filed 2025-02-26 | $216.00K derived: sum of 3 quarters · filed 2025-02-26 | $280.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | $77.00K 10-Q · filed 2023-11-01 | $133.00K derived: sum of 2 quarters · filed 2023-11-01 | $197.00K 10-Q · filed 2023-11-01 | $283.00K derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $56.00K 10-Q · filed 2023-08-02 | $120.00K 10-Q · filed 2023-08-02 | $206.00K derived: sum of 3 quarters · filed 2024-02-15 | $253.00K derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $64.00K 10-Q · filed 2023-05-03 | $150.00K derived: sum of 2 quarters · filed 2024-02-15 | $197.00K derived: sum of 3 quarters · filed 2024-02-15 | $260.00K derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $133.00K derived: sum of 2 quarters · filed 2024-02-15 | $196.00K derived: sum of 3 quarters · filed 2024-02-15 | $237.00K 10-K · filed 2024-02-15 |
| 2021-09-30 | $47.00K 10-Q · filed 2022-11-03 | $110.00K derived: sum of 2 quarters · filed 2022-11-03 | $151.00K 10-Q · filed 2022-11-03 | $207.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $63.00K 10-Q · filed 2022-08-04 | $104.00K 10-Q · filed 2022-08-04 | $160.00K derived: sum of 3 quarters · filed 2023-02-28 | $213.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $41.00K 10-Q · filed 2022-05-05 | $97.00K derived: sum of 2 quarters · filed 2023-02-28 | $150.00K derived: sum of 3 quarters · filed 2023-02-28 | $209.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $109.00K derived: sum of 2 quarters · filed 2023-02-28 | $168.00K derived: sum of 3 quarters · filed 2023-02-28 | $238.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $53.00K 10-Q · filed 2021-11-03 | $112.00K derived: sum of 2 quarters · filed 2021-11-03 | $182.00K 10-Q · filed 2021-11-03 | $197.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $59.00K 10-Q · filed 2021-07-29 | $129.00K 10-Q · filed 2021-07-29 | $144.00K derived: sum of 3 quarters · filed 2022-02-15 | $166.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $70.00K 10-Q · filed 2021-05-06 | $85.00K derived: sum of 2 quarters · filed 2022-02-15 | $107.00K derived: sum of 3 quarters · filed 2022-02-15 | $162.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $37.00K derived: sum of 2 quarters · filed 2022-02-15 | $92.00K derived: sum of 3 quarters · filed 2022-02-15 | $120.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | $22.00K 10-Q · filed 2020-11-03 | $77.00K derived: sum of 2 quarters · filed 2020-11-03 | $105.00K 10-Q · filed 2020-11-03 | $192.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $55.00K 10-Q · filed 2020-08-04 | $83.00K 10-Q · filed 2020-08-04 | $170.00K derived: sum of 3 quarters · filed 2021-02-23 | $170.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $28.00K 10-Q · filed 2020-05-04 | $115.00K derived: sum of 2 quarters · filed 2021-02-23 | $115.00K derived: sum of 3 quarters · filed 2021-02-23 | $115.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $87.00K derived: sum of 2 quarters · filed 2021-02-23 | $87.00K derived: sum of 3 quarters · filed 2021-02-23 | $87.00K 10-K · filed 2021-02-23 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |